FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311666188> ?p ?o ?g. }

• W4311666188 abstract "Abstract Oncotherapeutics research is progressing at a rapid pace, however, not many drugs complete the successful clinical trial because of severe off-target toxicity to cardiomyocytes which ultimately leads to cardiac dysfunction. It is thus important to emphasize the need for early testing for possible cardiotoxicity of emerging oncotherapeutics. In this study, we assessed a novel stem cell-derived cardiac model for testing for cardiotoxicity of novel oncotherapeutics. We evaluated the cardiotoxic effect of synthesized derivatives of oncotherapeutics, quercetin (QMJ-2, -5, and -6) and cinnamic acid (NMJ-1, -2, and -3) using human Wharton's jelly mesenchymal stem cells-derived cardiomyocytes (WJCM) against known cardiotoxic oncologic drugs, doxorubicin, 5-fluorouracil, cisplatin. QMJ-6, NMJ-2, and NMJ-3 were not cardiotoxic and had minimum cardiac side effects. They did not show any effect on cardiomyocyte viability, caused low LDH release, and intracellular ROS production kept the calcium flux minimal and protected the active mitochondrial status in cardiomyocytes. They persevered cardiac-specific gene expression as well. However, compounds QMJ-2, QMJ-5, and NMJ-1 were cardiotoxic and the concentration needs to be reduced to prevent toxic effects on cardiomyocytes. Significantly, we were able to demonstrate that WJCM is an efficient cardiac testing model to analyze the cardiotoxicity of drugs in a human context." @default.
• W4311666188 created "2022-12-27" @default.
• W4311666188 creator A5005709083 @default.
• W4311666188 creator A5034304968 @default.
• W4311666188 creator A5035016726 @default.
• W4311666188 creator A5057308257 @default.
• W4311666188 creator A5057825310 @default.
• W4311666188 creator A5068822651 @default.
• W4311666188 date "2022-12-09" @default.
• W4311666188 modified "2023-09-27" @default.
• W4311666188 title "An efficient human stem cells derived cardiotoxicity testing platform for testing oncotherapeutic analogues of quercetin and cinnamic acid" @default.
• W4311666188 cites W1518251028 @default.
• W4311666188 cites W1602031286 @default.
• W4311666188 cites W1758519974 @default.
• W4311666188 cites W1914076265 @default.
• W4311666188 cites W1923485987 @default.
• W4311666188 cites W1925085094 @default.
• W4311666188 cites W1974024889 @default.
• W4311666188 cites W1975627517 @default.
• W4311666188 cites W1976083636 @default.
• W4311666188 cites W1977510259 @default.
• W4311666188 cites W1977622321 @default.
• W4311666188 cites W1986853728 @default.
• W4311666188 cites W1988862392 @default.
• W4311666188 cites W2001219281 @default.
• W4311666188 cites W2004707205 @default.
• W4311666188 cites W2023571753 @default.
• W4311666188 cites W2040915373 @default.
• W4311666188 cites W2043401892 @default.
• W4311666188 cites W2045574035 @default.
• W4311666188 cites W2051068199 @default.
• W4311666188 cites W2056486110 @default.
• W4311666188 cites W2067834484 @default.
• W4311666188 cites W2070345146 @default.
• W4311666188 cites W2080836140 @default.
• W4311666188 cites W2087627491 @default.
• W4311666188 cites W2094657005 @default.
• W4311666188 cites W2121885558 @default.
• W4311666188 cites W2122341467 @default.
• W4311666188 cites W2137410755 @default.
• W4311666188 cites W2142877037 @default.
• W4311666188 cites W2150076823 @default.
• W4311666188 cites W2153362990 @default.
• W4311666188 cites W2153949260 @default.
• W4311666188 cites W2154267665 @default.
• W4311666188 cites W2279656465 @default.
• W4311666188 cites W2323039205 @default.
• W4311666188 cites W2340500956 @default.
• W4311666188 cites W2345547795 @default.
• W4311666188 cites W2411636592 @default.
• W4311666188 cites W2467851095 @default.
• W4311666188 cites W2508734629 @default.
• W4311666188 cites W2519786994 @default.
• W4311666188 cites W2540144723 @default.
• W4311666188 cites W2602558740 @default.
• W4311666188 cites W2746624202 @default.
• W4311666188 cites W2779110724 @default.
• W4311666188 cites W2797594483 @default.
• W4311666188 cites W2803627340 @default.
• W4311666188 cites W288270733 @default.
• W4311666188 cites W2889646458 @default.
• W4311666188 cites W2900319190 @default.
• W4311666188 cites W2906460811 @default.
• W4311666188 cites W2907214376 @default.
• W4311666188 cites W2908446822 @default.
• W4311666188 cites W2911478829 @default.
• W4311666188 cites W2923614429 @default.
• W4311666188 cites W2948077402 @default.
• W4311666188 cites W2951071083 @default.
• W4311666188 cites W2973068260 @default.
• W4311666188 cites W2974044942 @default.
• W4311666188 cites W2980351756 @default.
• W4311666188 cites W2985777746 @default.
• W4311666188 cites W3000627274 @default.
• W4311666188 cites W3006683993 @default.
• W4311666188 cites W3009858127 @default.
• W4311666188 cites W3015958768 @default.
• W4311666188 cites W3016770414 @default.
• W4311666188 cites W3019982879 @default.
• W4311666188 cites W3028352416 @default.
• W4311666188 cites W3036591244 @default.
• W4311666188 cites W3084685848 @default.
• W4311666188 cites W3090916670 @default.
• W4311666188 cites W3091980601 @default.
• W4311666188 cites W3109992463 @default.
• W4311666188 cites W3125838323 @default.
• W4311666188 cites W3160992829 @default.
• W4311666188 cites W3196370495 @default.
• W4311666188 cites W375942940 @default.
• W4311666188 cites W4200249847 @default.
• W4311666188 cites W4206918415 @default.
• W4311666188 doi "https://doi.org/10.1038/s41598-022-21721-3" @default.
• W4311666188 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36494370" @default.
• W4311666188 hasPublicationYear "2022" @default.
• W4311666188 type Work @default.
• W4311666188 citedByCount "1" @default.
• W4311666188 countsByYear W43116661882023 @default.
• W4311666188 crossrefType "journal-article" @default.
• W4311666188 hasAuthorship W4311666188A5005709083 @default.
• W4311666188 hasAuthorship W4311666188A5034304968 @default.

• next